Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
Sponsor: National Institute of Mental Health (NIMH)
A PHASE2/PHASE3 clinical study on Post-traumatic Stress Disorder and Self-injurious Behavior, this trial is completed. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Jun 2018 — Oct 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Apr 2017 — May 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Mental Health (NIMH)
- University of Washington
For direct contact, visit the study record on ClinicalTrials.gov .